69 related articles for article (PubMed ID: 21624903)
1. Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway.
Tsuburaya R; Yasuda S; Shiroto T; Ito Y; Gao JY; Aizawa K; Kikuchi Y; Ito K; Takahashi J; Ishibashi-Ueda H; Shimokawa H
Eur Heart J; 2012 Mar; 33(6):791-9. PubMed ID: 21624903
[TBL] [Abstract][Full Text] [Related]
2. Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo.
Shiroto T; Yasuda S; Tsuburaya R; Ito Y; Takahashi J; Ito K; Ishibashi-Ueda H; Shimokawa H
J Am Coll Cardiol; 2009 Dec; 54(24):2321-9. PubMed ID: 19958969
[TBL] [Abstract][Full Text] [Related]
3. Association of Coronary Perivascular Adipose Tissue Inflammation and Drug-Eluting Stent-Induced Coronary Hyperconstricting Responses in Pigs:
Ohyama K; Matsumoto Y; Amamizu H; Uzuka H; Nishimiya K; Morosawa S; Hirano M; Watabe H; Funaki Y; Miyata S; Takahashi J; Ito K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1757-1764. PubMed ID: 28751570
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo.
Nishimiya K; Matsumoto Y; Uzuka H; Ogata T; Hirano M; Shindo T; Hasebe Y; Tsuburaya R; Shiroto T; Takahashi J; Ito K; Shimokawa H
JACC Cardiovasc Interv; 2016 Feb; 9(3):281-291. PubMed ID: 26847120
[TBL] [Abstract][Full Text] [Related]
5. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
[TBL] [Abstract][Full Text] [Related]
6. Renal Denervation Suppresses Coronary Hyperconstricting Responses After Drug-Eluting Stent Implantation in Pigs In Vivo Through the Kidney-Brain-Heart Axis.
Uzuka H; Matsumoto Y; Nishimiya K; Ohyama K; Suzuki H; Amamizu H; Morosawa S; Hirano M; Shindo T; Kikuchi Y; Hao K; Shiroto T; Ito K; Takahashi J; Fukuda K; Miyata S; Funaki Y; Ishibashi-Ueda H; Yasuda S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1869-1880. PubMed ID: 28818859
[TBL] [Abstract][Full Text] [Related]
7. Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease.
Aizawa K; Yasuda S; Takahashi J; Takii T; Kikuchi Y; Tsuburaya R; Ito Y; Ito K; Nakayama M; Takeda M; Shimokawa H
Circ J; 2012; 76(11):2552-60. PubMed ID: 22813839
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Lymphatic Dysfunction Causes Drug-Eluting Stent-Induced Coronary Hyperconstricting Responses in Pigs In Vivo.
Amamizu H; Matsumoto Y; Morosawa S; Ohyama K; Uzuka H; Hirano M; Nishimiya K; Gokon Y; Watanabe-Asaka T; Hayashi M; Miyata S; Kamei T; Kawai Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):741-753. PubMed ID: 30816801
[TBL] [Abstract][Full Text] [Related]
9. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
10. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: The NOVEL study.
Tsuburaya R; Takahashi J; Nakamura A; Nozaki E; Sugi M; Yamamoto Y; Hiramoto T; Horiguchi S; Inoue K; Goto T; Kato A; Shinozaki T; Ishida E; Miyata S; Yasuda S; Shimokawa H;
Eur Heart J; 2016 Sep; 37(35):2713-21. PubMed ID: 27354043
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
[TBL] [Abstract][Full Text] [Related]
13. Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo.
Watanabe T; Matsumoto Y; Nishimiya K; Shindo T; Amamizu H; Sugisawa J; Tsuchiya S; Sato K; Morosawa S; Ohyama K; Watanabe-Asaka T; Hayashi M; Kawai Y; Takahashi J; Yasuda S; Shimokawa H
PLoS One; 2021; 16(9):e0257175. PubMed ID: 34516572
[TBL] [Abstract][Full Text] [Related]
14. Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis.
Kleinbongard P; Böse D; Konorza T; Steinhilber F; Möhlenkamp S; Eggebrecht H; Baars T; Degen H; Haude M; Levkau B; Erbel R; Heusch G
Basic Res Cardiol; 2011 Jun; 106(4):681-9. PubMed ID: 21472462
[TBL] [Abstract][Full Text] [Related]
15. Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo: a possible link between stress and coronary vasospasm.
Hizume T; Morikawa K; Takaki A; Abe K; Sunagawa K; Amano M; Kaibuchi K; Kubo C; Shimokawa H
Circ Res; 2006 Sep; 99(7):767-75. PubMed ID: 16960099
[TBL] [Abstract][Full Text] [Related]
16. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
18. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
[TBL] [Abstract][Full Text] [Related]
19. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
Llano R; Winsor-Hines D; Patel DB; Seifert PS; Hamamdzic D; Wilson GJ; Wang H; Keane MG; Huibregtse BA; Wilensky RL
Circ Cardiovasc Interv; 2011 Oct; 4(5):438-46. PubMed ID: 21972400
[TBL] [Abstract][Full Text] [Related]
20. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
